Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000242998 | SCV000309154 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000391534 | SCV000405882 | benign | Acrodysostosis | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000295961 | SCV000405883 | benign | Carney complex | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000566192 | SCV000664949 | benign | Hereditary cancer-predisposing syndrome | 2020-07-10 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001521654 | SCV001731032 | benign | Carney complex, type 1 | 2025-02-04 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001659926 | SCV001881234 | benign | not provided | 2021-05-21 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001521654 | SCV002031842 | benign | Carney complex, type 1 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789000 | SCV002031843 | benign | Acrodysostosis 1 with or without hormone resistance | 2021-10-25 | criteria provided, single submitter | clinical testing |